Broadcom AI Guidance Spurs Selloff, Nvidia Remains Leader
Broadcom kept its AI growth outlook steady for the next quarter, but the stock dropped sharply as investors priced in...
Which Crypto Has Real Project Utility
Analyze which crypto assets deliver real project utility, looking at use cases, partnerships, and on-chain activity to gauge authenticity.
28,337 articles
Shocked Running Berkshire Hathaway’s Portfolio: Who Leads Now
Berkshire Hathaway sits on a massive stock portfolio and a mountain of cash. As leadership quietly shifts, investors ...
Will SpaceX Years? Here's What Experts Say About Growth
The next five years could redefine SpaceX’s place in markets from launches to internet services. This guide breaks do...
Which Companies Benefit Most From Tariff Easing
Investor chatter centers on which these companies benefits most as U.S.-China tariff talks re-emerge. A closer look a...
CertifID Launches Unified Closing Platform to Streamline
CertifID debuts a mobile-first closing platform that centralizes identity verification, document signing, and payment...
Reason Investors Shouldn't Worry About AI Stock's Biggest Risk
Artificial intelligence is reshaping markets, but one big risk many investors fear may be overblown. This article exp...
IonQ Tripled Revenue, Yet Stock Dips as Losses Expand
IonQ posted triple-digit revenue growth for 2025, reaching a new high, while losses intensified. The stock has fallen...
Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
OpenAI Capital Push: Open Should Strike While Hot Now
Private AI leaders OpenAI and Anthropic see valuations near $1 trillion as investors chase growth. A cooling IPO wind...
NANC Investors Have 45-Day Blind Spot as Rates Rise
The NANC ETF, built to mirror congressional disclosure trades, is facing a tougher 2026 as interest rates move higher...
Banks Paying Again: Financial Dividend Revival in 2026
U.S. lenders are accelerating cash returns to shareholders after stress tests and capital rules ease. JPMorgan, Bank ...
Ionis Pharmaceuticals Drops Another After Phase 3 Setback
Ionis Pharmaceuticals dropped again after a Phase 3 failure in transthyretin amyloid cardiomyopathy, triggering a bro...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status